Clinical Trials Arena September 17, 2025
Trially will accelerate the adoption of its platform across research sites, CROs, physician networks, and pharma sponsors.
Clinical trial recruitment platform Trially has raised $4.7m in a seed funding round and introduced its agentic AI solution, Margo, designed to increase study enrolment by converting patient matches into actual subjects.
The company said that 86% of trials experience delays due to recruitment issues, resulting in the pharma industry incurring significant losses daily, while patients endure lengthy waits for potentially life-saving treatments.
As the first fully integrated AI platform designed to address these delays, Trially employs Health Insurance Portability and Accountability Act (HIPAA)-compliant large language model (LLM) agents that can analyse medical data that is not structured, for matching, connecting, and enrolling...
Today's Sponsors
Today's Sponsor